Business Analysis 12 February 2026

Business Analysis·Finance·NASDAQ:OGI·News·Stock Market·TSX:OGI

Organigram Stock Bounces Off Lows; Margins in Focus Next

Organigram’s Nasdaq shares closed Friday at $1.12, down 0.9% but up 4.7% from May 15, while its TSX shares ended at C$1.56. The company reported a C$0.9 million net loss for the quarter, with revenue down 9% to C$59.8 million. U.S. and Canadian exchanges are split by holidays, with Nasdaq closed Monday for Memorial Day. Organigram raised its 2026 revenue forecast above C$350 million after acquiring Sanity Group.

May 24, 2026

Business Analysis·News·Stock Market·Technology

Cisco stock price drops nearly 8% in premarket after margin miss — what’s next for CSCO

Cisco shares fell 7.9% to $78.74 in premarket trading after quarterly results showed gross margin dropped to 67.5%, missing estimates due to higher memory costs. The company raised its full-year revenue outlook and reported $2.1 billion in AI infrastructure orders, but analysts flagged margin pressure and product mix concerns.

February 12, 2026

ASX Investors Face Hidden Overexposure to US 'Magnificent 7' Tech Giants
May 29, 2026, 8:06 PM EDT. Many Australian investors may unknowingly hold significant stakes in the US tech giants known as the 'Magnificent 7'-Microsoft, Amazon, Alphabet, Meta Platforms, Apple, Tesla, and NVIDIA. These companies dominate various US exchange-traded funds (ETFs) like BetaShares Nasdaq 100 (NDQ), Schwab U.S. Large-Cap Growth (SCHG), iShares S&P 500 (IVV), and others widely held in Australia. In addition, large positions in listed investment companies (LICs) such as MFF Capital and ETFs like VanEck Morningstar Wide Moat (MOAT) further increase exposure. Superannuation funds also typically include these stocks, amplifying collective investment risk. Investors should audit their portfolios to understand the extent of their indirect and direct holdings in these tech behemoths amid their growing market dominance.